Organic compounds -- part of the class 532-570 series inventions

20090270622 - Diphosphines and metal complexes: Compounds of the formula I or I′, where the radicals R1 are each, independently of one another, a hydrogen atom or C1-C4-alkyl and R′1, is C1-C4-alkyl; X1 and X2 are each, independently of one another, a sec-phosphino group; R2 is hydrogen, R01R02R03Si— is halogen-, hydroxyl-, C1-C8-alkoxy- or R04R05N-substituted C1-C18-acyl or... Agent: Wenderoth, Lind & Ponack, L.L.P.

20090270623 - Process for production of cinnamide derivative: m

20090270624 - Process for purifying noroxymorphone compounds: A process for purifying plant extracts which consist essentially of noroxymorphone compounds and which comprise, as impurities, α,β-unsaturated noroxymorphone compounds, by (a) converting the plant extract or the product of a subsequent stage in the synthesis of a selected noroxymorphone compound in a reaction which converts the hydroxyl groups present... Agent: Hammer & Associates, P.C.

20090270625 - Fused quinoline derivative and use thereof: p

20090270626 - Stable bisthiol compounds for radioimaging and therapy: The invention provides compounds and methods for preparing radiopharmaceutical compounds useful as therapeutic and diagnostic agents.... Agent: Edwards Angell Palmer & Dodge LLP

20090270627 - Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties: Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties are derived from the incorporation of electron active substituents in selective positions.... Agent: E I Du Pont De Nemours And Company Legal Patent Records Center

20090270628 - Process for making montelukast intermediates: o

20090270629 - Process for preparing quaternary salts of piperidyl esters of mandelic acid:

20090270630 - Process for the synthesis of benzylidene rosiglitazone base:

20090270631 - Therapeutic agent for diabetes: The present invention provides an agent for the prophylaxis or treatment of diabetes, which is associated with a fewer side effects such as body weight gain, adipocyte accumulation, cardiac hypertrophy and the like, and which contains a compound represented by the formula: wherein each symbol is as defined in the... Agent: Wenderoth, Lind & Ponack, L.L.P.

20090264656 - Method for manufacture of sertindole: The present invention relates to a novel method for manufacture of sertindole comprising manufacturing 5-chloro-1-(4-fluorophenyl)-indole and converting it to sertindole wherein the method for manufacture of 5-chloro-1-(4-fluorophenyl)-indole comprises reacting 5-chloro-indole with a 4-fluorophenylhalide in the presence of a base, a chelating ligand and catalytic amounts or a copper salt comprising... Agent: Lundbeck Research Usa, Inc. Attention: Stephen G. Kalinchak, Legal

20090264657 - Stabilization of body-care and household products against degradation by uv radiation using merocyanine derivatives: Described is the use of specific merocyanine derivatives for protecting body-care and household products from photolytic and oxidative degradation. These compounds perform outstanding UV absorber properties.... Agent: Joann Villamizar Ciba Corporation/patent Department

20090264658 - Salts of benzimidazole derivative with amines and process for manufacturing the same: s

20090264659 - Salts of benzimidazole derivative with amines and process for manufacturing the same:

20090264660 - Process for alkyl aryl sulfide derivatives and new sulfide compounds: An alkyl aryl sulfide of Chemical Formula (III) is prepared by substituting an aryl halogen compound of Chemical Formula (I) with an alkyl lithium organometallic reagent. The sulfide is subsequently reacted with a compound of Chemical Formula (II). Alternatively an aryl halogen compound of Chemical Formula (I) is reacted with... Agent: Lowe Hauptman Ham & Berner, LLP

20090259041 - Quinoline carboxylic acid-o,o bis-acyloxy borate and process of making: The intermediate (4aS-Cis)-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-me-thoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-O3,O4)bis(acyloxy-0) borate and a method of preparation. The intermediate is useful in an improved process for the preparation of moxifloxacin hydrochloride from ethyl 1-cyclopropyl 6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinolinecarboxylate.... Agent: Schweitzer Cornman Gross & Bondell LLP

20090259042 - Electrochromic compounds: The invention concerns electrochromic compounds of the general formula I. These compounds may be used in electrochromic devices, especially electrochromic devices comprising nanostructured films.... Agent: Morgan, Lewis & Bockius LLP

20090259043 - Tricyclic cytoprotective compounds: [in which: X is a group of formula >CR1R2 or >SO2; Y is a group of formula >NH or >CR1R2; Z is a group of formula >C═O or >CH2 or a direct bond; R1 is hydrogen and R2 is hydrogen, carboxy or hydroxy; or R1 and R2 together represent an... Agent: Greenlee Winner And Sullivan P C

20090259044 - Compositions and methods for modulating sirtuin activity: The present invention is based, in part, on our discovery of compounds that inhibit an activity of a sirtuin (e.g., compounds that inhibit or preferentially inhibit an activity of SIRT2) and are therefore believed useful in the treatment or prevention of diseases associated with sirtuin activity. These diseases include, but... Agent: David S. Resnick

20090259045 - Process for production of azabicycloalkanol derivative: The object is to produce an azabicycloalkanol derivative, particularly a cis-3-substituted-3-azabicyclo[3.2.1]octan-8-ol derivative which is a useful intermediate for agricultural chemicals or pharmaceutical agents, with a good yield and at an industrially low cost. A diastereomer of an azabicyclo-C6-10-alkanol derivative having a methyne substituted a hydroxyl group as an asymmetric carbon... Agent: Oliff & Berridge, PLC

20090259046 - Cyclic amine compounds and agents for pest control: e

20090259047 - Barium salt of benzimidazole derivative: The invention relates to crystalline barium salt of (S)-omeprazole, which is (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole. The invention also relates to processes for preparing crystalline barium salt of (S)-omeprazole and pharmaceutical compositions that include the crystalline barium salt of (S)-omeprazole so prepared.... Agent: Jayadeep R. Deshmukh, Esq. Ranbaxy Inc.

20090259048 - Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases: The present disclosure provides non-naturally occurring polyphenol compounds that upregulate the expression of Apolipoprotein A-I (ApoA-I). The disclosed compositions and methods can be used for treatment and prevention of cardiovascular disease and related disease states, including cholesterol or lipid related disorders, such as, e.g., atherosclerosis.... Agent: Finnegan, Henderson, Farabow, Garrett & Dunner LLP

20090253910 - Phosphorescent materials: Phosphorescent organometallic materials are provided, comprising at least one 3-arylacetylacetone ligand. Processes for making such materials, and to organic light emitting devices comprising the materials, are also provided.... Agent: Townsend And Townsend And Crew, LLP

20090253911 - New compounds useful for the synthesis of s- and r-omeprazole and a process for their preparation: The present invention relates to an improved method for the synthesis of the (S)- or (R)-enantiomer of omeprazole, characterized in that 2-[[(4-X-3,5-dimethylpyridin-2-yl)methyl]thio]-5-methoxy-1H-benzimidazole or 2-[[(4-X-3,5-dimethyl-1-oxidopyridin-2-yl)methyl]thio]-5-methoxy-1H-benzimidazole, wherein X is a leaving group, is oxidized into the corresponding sulphoxide which is obtained as a crystalline compound. Recrystallisation of the thus obtained sulphoxide results... Agent: White & Case LLP Patent Department

20090253912 - Process for the preparation of onium salts with a tetrafluoroborate anion having a reduced halide content: The invention relates to a method for producing onium salts with tetrafluoroborate anion by reacting an onium halide with an oxonium tetrafluoroborate, sulfonium tetrafluoroborate, or triphenylcarbonium tetrafluoroborate.... Agent: Millen, White, Zelano & Branigan, P.C.

20090253913 - Process for the preparation of sorafenib and salts thereof: Methods for the synthesis of the N-carbamoyl imidazole (I) and its 1:1 adduct with imidazole are provided. Methods for the preparation of these crystalline intermediates in a high state of purity are also provided. These intermediates react cleanly under mild conditions to produce sorafenib in high yield and purity, without... Agent: Kenyon & Kenyon LLP

20090253914 - Process for the preparation of onium salts with dialkylphosphate, dialkylphosphinate or (o-alkyl)alkyl- or alkylphosphonate anions having a low halide content: The invention relates to a process for the preparation of onium salts with dialkylphosphate, dialkylphosphinate or (O-alkyl)alkyl- or alkylphosphonate anions by reaction of an onium halide with a triallyl phosphate, alkyl dialkylphosphinate, dialkyl alkylphosphonate or trialkylsilyl ester or mixed alkyl trialkylsilyl ester of phosphoric, dialkylphosphinic or alkylphosphonic acid.... Agent: Millen, White, Zelano & Branigan, P.C.